Improved Therapeutic Benefits by Combining Physical Cooling With Pharmacological Hypothermia After Severe Stroke in Rats [Basic Sciences]

Conclusions—
The centrally acting hypothermic drug HPI-201 greatly enhanced the efficiency and efficacy of conventional PC; this combined cooling therapy may facilitate clinical translation of hypothermic treatment for stroke.

Source: Stroke - June 26, 2016 Category: Neurology Authors: Lee, J. H., Wei, L., Gu, X., Won, S., Wei, Z. Z., Dix, T. A., Yu, S. P. Tags: Ischemic Stroke, Neuroprotectants Basic Sciences Source Type: research